These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27388453)

  • 1. Thoracic magnetic resonance venography using Gadofosveset in patients with venous pathology-A comparative study of image quality and inter-rater variability.
    Åkesson M; Lehti L; Höglund P; Åkeson P; Wassélius J
    Phlebology; 2017 Aug; 32(7):453-458. PubMed ID: 27388453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadofosveset-enhanced magnetic resonance venography in patients with venous pathology of the lower limbs - Comparison of diagnostic image quality and inter-rater variability with gadobutrol venography and computed tomography venography.
    Åkesson M; Lehti L; Höglund P; Åkeson P; Wassélius J
    Phlebology; 2016 Dec; 31(10):737-743. PubMed ID: 26631538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
    Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
    Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadofosveset-enhanced thoracic MR venography: a comparative study evaluating steady state imaging versus conventional first-pass time-resolved dynamic imaging.
    See TC; Patterson AJ; Hilliard NJ; Soh E; Winterbottom AP; Patterson I; Parker RA; Graves MJ; Lomas DJ
    Acta Radiol; 2018 Apr; 59(4):418-424. PubMed ID: 28707958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities.
    Arnoldussen CWKP; Lam Y; Ito N; Winkens B; Kooi ME; Wittens CHA; Wildberger JE
    Eur Radiol; 2017 Dec; 27(12):4986-4994. PubMed ID: 28674964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of blood pool and extracellular gadolinium chelate for functional MR evaluation of vascular thoracic outlet syndrome.
    Lim RP; Bruno M; Rosenkrantz AB; Kim DC; Mulholland T; Kwon J; Palfrey AP; Ogedegbe O
    Eur J Radiol; 2014 Jul; 83(7):1209-1215. PubMed ID: 24840478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
    Bashir MR; Mody R; Neville A; Javan R; Seaman D; Kim CY; Gupta RT; Jaffe TA
    J Magn Reson Imaging; 2014 Jul; 40(1):113-8. PubMed ID: 24130008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis.
    Partovi S; Aschwanden M; Staub D; Rasmus M; Zipp L; Rengier F; Jacobi B; Hügli R; Bilecen D
    Vasa; 2011 Jul; 40(4):315-9. PubMed ID: 21780056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance venography and liver transplant complications.
    Strovski E; Liu D; Scudamore C; Ho S; Yoshida E; Klass D
    World J Gastroenterol; 2013 Sep; 19(36):6110-3. PubMed ID: 24106414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
    Pfeil A; Betge S; Poehlmann G; Boettcher J; Drescher R; Malich A; Wolf G; Mentzel HJ; Hansch A
    Eur J Radiol; 2012 Mar; 81(3):547-52. PubMed ID: 21349675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium.
    Kupczyk PA; Willinek WA; Hadizadeh DR; Traeber F; Gieseke J; Meyer C; Schild HH; Kukuk GM
    Magn Reson Imaging; 2015 Dec; 33(10):1258-1266. PubMed ID: 26271178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
    Johnson JT; Robinson JD; Deng J; Rigsby CK
    Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic central venous evaluation: comparison of first-pass direct versus delayed-phase indirect multidetector CT venography.
    Sundaram B; Kuriakose JW; Stojanovska J; Watcharotone K; Parker RA; Kazerooni EA
    Clin Imaging; 2015; 39(3):412-6. PubMed ID: 25724223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.
    Huang SY; Kim CY; Miller MJ; Gupta RT; Lessne ML; Horvath JJ; Boll DT; Evans PD; Befera NT; Krishnan P; Chan JL; Merkle EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):208-14. PubMed ID: 23789677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T1-weighted sequences.
    Boettcher J; Pfeil A; Wolf G; Hansch A
    Clin Imaging; 2013; 37(2):245-50. PubMed ID: 23465975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadofosveset.
    Henness S; Keating GM
    Drugs; 2006; 66(6):851-7. PubMed ID: 16706555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.